supraventricular tachycardia was terminated in 24 ( 86 % ) of 28 patients given intravenous diltiazem compared with 5 ( 19 % ) of 26 given placebo ( p = 0.0000014 ) .
C0039240
supraventricular tachycardia
C0012373
diltiazem